London
){kind=logo}
Samsung Bioepis is a biopharmaceutical company specializing in the development and commercialization of biosimilar medicines. Founded in 2012 in South Korea, it is a fully-owned subsidiary of Samsung Biologics. The company's mission is to increase access to high-quality, affordable biologic medicines for patients.
Samsung Bioepis has built an expansive portfolio of biosimilars across several therapeutic areas, including immunology, oncology, and ophthalmology. It works with commercial partners like Organon and Sandoz to market and distribute its products globally. Using innovative science and technology, the company focuses on delivering medicines faster and more efficiently.
